| Sign In to gain access to subscriptions and/or personal tools. |
Evaluation of the Developmental Toxicity of Dihydromyrcenol in RatsFrom the Research Institute for Fragrance Materials, Inc, Woodcliff Lake, New Jersey; Charles River Laboratories Preclinical Services, Horsham, Pennsylvania; Argus International, Inc, Horsham, Pennsylvania; and Research Institute for Fragrance Materials, Inc, Woodcliff Lake, New Jersey Correspondence: Address correspondence to Valerie T. Politano, PhD, Research Institute for Fragrance Materials, Inc, 50 Tice Boulevard, Woodcliff Lake, NJ 07677; e-mail:vpolitano{at}rifm.org.
Dihydromyrcenol, a widely used fragrance ingredient, was evaluated for developmental toxicity in pregnant Sprague-Dawley rats (25/group). Oral dosages of 0, 250, 500, or 1000 mg/kg/d in corn oil were administered on gestational days 7 to 17. Rats were observed for viability, clinical signs, body weights, and feed consumption. Caesarean sectioning and necropsy occurred on gestational day 21. Fetuses were weighed and examined for sex, gross external changes, and soft tissue or skeletal alterations. All rats survived until scheduled termination. No clinical signs were attributed to dihydromyrcenol. There were no gross tissue changes at necropsy. The 1000-mg/kg/d dosage group had reduced mean maternal body weight gains of 5% compared with controls, whereas absolute and relative feed consumption were significantly reduced during the dosage period. This threshold systemic maternal toxicity was associated with threshold developmental toxicity in the 1000-mg/kg/d dosage group. Fetal effects included a minimal
Key Words: CAS #18479-58-8 • CAS #25279-09-8 • developmental toxicity • dihydromyrcenol • fragrance
International Journal of Toxicology, Vol. 28, No. 2,
80-87 (2009) |
||||
 |
|
|
 |
|
Sign In to gain access to subscriptions and/or personal tools.
3% reduction in fetal body weight; reversible variations in ossification, including retarded ossification of the metatarsal bones in the hindpaws; and an increase in supernumerary thoracic ribs with associated increases or decreases in thoracic and lumbar vertebrae, respectively. Based on these data, maternal and developmental no observable effect levels of 500 mg/kg/d and maternal and developmental no observable adverse effect levels of 1000 mg/kg/d were established for dihydromyrcenol. It was concluded that dihydromyrcenol is not a selective developmental toxicant in rats under the conditions of this study and that a margin of safety of 25 000 exists between reversible developmental delays in rats and the estimated daily human exposure level of 0.02 mg/kg/d.